Key facts
- This page summarizes Naresh Haresh Tanna's Form 3 filing for PRECISION BIOSCIENCES INC (DTIL).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2026, 07:16.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
On April 18, 2024, the reporting person was granted 16,683 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Footnote F2
The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
Footnote F3
On August 22, 2024, the reporting person was granted 33,317 RSUs, which vest in three substantially equal annual installments beginning on January 27, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Footnote F4
On June 2, 2025, the reporting person was granted 45,000 RSUs, which vest in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Footnote F5
On June 1, 2026, the reporting person was granted 179,340 RSUs, which vest in three substantially equal annual installments beginning on February 19, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
SEC remarks
Exhibit 24 - Power of Attorney